Key facts
- Pression’s last known valuation is $37.8M (May 2025).
- It has raised $13.9M across 2 recorded rounds; the latest was Seed Round ($370K) in Mar 2021.
- Notable investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, Innovation Partnership, LifeX Ventures, Nextfab Ventures, The Accelerator Centre — 6 tracked in total.
- Pression has filed 2 Form Ds with the SEC since 2021, most recently Dec 2024 ($2.5M sold to 18 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Pression
Funding rounds
2 roundsAbout Pression
Developer of a patented, non-invasive compression system designed to enhance independence for those patients suffering from circulatory conditions. The company Wave recovery system offers a healthy life for those patients suffering from circulatory conditions, enabling the patients to improve exercise tolerance and quality of life.
- Sector
- Healthcare
- HQ
- Coatesville, PA, United States
- Founded
- 2016
- Employees
- 10
- Website
- pression.com/
- Ownership
- Privately Held (backing)
Pression doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pression shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pression in its N-PORT filings yet. We sweep new filings monthly.